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Abstract
Reducing disease prevalence through selection for host resistance offers a desirable alternative to chemical treatment.
Selection for host resistance has proven difficult, however, due to low heritability estimates. These low estimates may be
caused by a failure to capture all the relevant genetic variance in disease resistance, as genetic analysis currently is not
taylored to estimate genetic variation in infectivity. Host infectivity is the propensity of transmitting infection upon contact
with a susceptible individual, and can be regarded as an indirect effect to disease status. It may be caused by a combination
of physiological and behavioural traits. Though genetic variation in infectivity is difficult to measure directly, Indirect Genetic
Effect (IGE) models, also referred to as associative effects or social interaction models, allow the estimation of this variance
from more readily available binary disease data (infected/non-infected). We therefore generated binary disease data from
simulated populations with known amounts of variation in susceptibility and infectivity to test the adequacy of traditional
and IGE models. Our results show that a conventional model fails to capture the genetic variation in infectivity inherent in
populations with simulated infectivity. An IGE model, on the other hand, does capture some of the variation in infectivity.
Comparison with expected genetic variance suggests that there is scope for further methodological improvement, and that
potential responses to selection may be greater than values presented here. Nonetheless, selection using an index of
estimated direct and indirect breeding values was shown to have a greater genetic selection differential and reduced future
disease risk than traditional selection for resistance only. These findings suggest that if genetic variation in infectivity
substantially contributes to disease transmission, then breeding designs which explicitly incorporate IGEs might help reduce
disease prevalence.
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Introduction
Infectious diseases in livestock constitute a major threat to the
sustainability of livestock production. Moreover, the need to
contain epidemics has been further emphasized by the threat of
transmission to other species – in particular humans – as illustrated
in the recent swine flu epidemic [1]. Reducing disease prevalence
through selection for host resistance offers a desirable alternative
to chemical treatment which is a potential environmental concern
due to run-off, and sometimes only offers limited protection due to
pathogen resistance [2,3]. However, control of infectious diseases
through selection has proven difficult as genetic analyses of
resistance to infectious disease from field data tend to report low
heritabilities [4]. But is this a reflection of true genetic variance?
Current genetic analyses of disease data tend to focus on
individual susceptibility to infectious disease, ignoring information
from group members. However, using a stochastic epidemiological
model, Nath et al. [5] identified the transmission rate, latent period
and recovery period as critical parameters for the risk and severity
of infectious disease. In other terms, Nath et al. [5] identified the
impact that individuals have on each other as critical parameters
for the risk and severity of infectious disease. Moreover,
evolutionary theory would suggest that more genetic variation
may be found in an individual’s impact on its groupmates than in
susceptibility. Since an individual’s susceptibility is a component of
its own fitness, natural selection works to exhaust heritable
variation in susceptibility. An individual’s impact on its group-
mates, in contrast, is not a component of its fitness, and may
therefore accumulate greater heritable variation [6]. As demon-
strated by Van Dyken et al. [7] this would occur even when kin-
selection is acting, as populations in kin selection-mutation balance
contain a stable frequency of ‘cheaters’. In the context of disease,
‘cheaters’ correspond to hosts with increased shedding of infectious
pathogens which has no damage to their own fitness but a
potentially high cost to the herd. For example, assuming that
animals with a greater parasite burden will also shed more, Raberg
et al. [8] found genetic variation in anaemia and weight loss
corresponding to increasing parasite burden of rodent malaria in
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opportunity in capturing genetic variation in host infectivity,
which is the propensity of transmitting infection upon contact with
a susceptible individual. Especially as, there is abundant evidence
that heterogeneity in infectivity can profoundly impact upon
disease prevalence in the population, with super-shedders being an
extreme example [9–12].
Over the last forty years, the theory of Indirect Genetic Effects
(IGE) has been developed to investigate the impact of interactions
among individuals on the expression and evolution of traits [13–
16]. An indirect genetic effect, also known as an associative or
social genetic effect, is a heritable effect of an individual on the
trait value of another individual [14]. Indeed, if an individual’s
trait value is affected by the genotypes of its population members
(indirect genetic effect), then response to selection will be affected
by these IGEs. It has been shown both theoretically [13,14,17] and
experimentally [18] that IGEs can drastically affect the rate and
direction of response to selection. In this context, host infectivity
can be regarded as an indirect effect to disease status. Thus an
individual’s disease status and infectious disease prevalence in a
population is likely to be affected by host genetic variation in both
susceptibility and infectivity. To date, however, no work has been
published examining the prospects of IGE models for infectious
diseases, suggesting that part of the heritable variation underlying
disease prevalence is overlooked.
Genetic variation in infectivity is difficult to measure directly
and may need to be inferred from more readily available
information such as binary disease data (infected/non-infected).
Our hypothesis is that current genetic models applied to binary
disease data do not capture the full genetic variation underlying
disease prevalence and that a model including IGEs is more
appropriate. This study, therefore, examines to what extent
genetic variance in infectivity/susceptibility is captured by a
conventional model versus an IGE model in populations with
simulated genetic variation in infectivity, and whether selection on
breeding values estimated with IGE models offer greater potential
for reducing disease prevalence. In order to address this question,
we modelled disease progression in populations with different
genetic architectures for infectivity/susceptibility and estimated
the genetic variance in the simulated binary disease data with a
conventional animal model and a model including IGEs. Finally,
we evaluated selection response in susceptibility and infectivity,
and its impact on future disease risk, using the estimated breeding
values (EBV) derived from both models.
Methods
The epidemiological model
An epidemic was simulated to describe disease progression in
the population and provide as output the disease status of each
individual at given time points. To avoid overburdening the results
with unnecessary complexity we chose a simple compartmental
stochastic SIR model of disease spread modified from [19]. In an
SIR model it is assumed that individuals start as being susceptible
(S) but may then become infected (I), upon contact with an
infected individual, eventually recover (R) and are then no longer
susceptible. The speed of transition between the epidemiological
compartments S, I, R is determined by the transmission parameter
b (S-.I) and by the recovery rate c (I-.R). It was also assumed
that infected individuals become immediately infectious. The
contact between individuals within a group was constant and
uniform (contact rate =1) and no transmission was allowed
between groups.
To allow for individual genetic variation in the epidemiological
parameters b and c, each individual j was assigned its own level of
susceptibility gj, infectivity fj and speed of recovery cj. The pairwise
transmission parameter bjk was then defined as
bjk~{ln(1{Xg,jgjXf,kfk): ð1Þ
We refer to Text S1 for the derivation of equation (1). For ease
of reading a comprehensive list of symbols and notation is given in
Table 1. Thus bjk is a function of the product of the susceptibility g
of individual j and the infectivity f of individual k. To reflect wether
susceptibility is expressed by individual j, it is scaled by Xg,j which
equals one if j is susceptible and zero otherwise. Similarly,
infectivity is scaled by Xf,k which equals one if k is infected and zero
otherwise. For simplicity, it was assumed that infectivity and
susceptibility are independent, and that all individual speeds of
recovery cj were assumed to be equal to a constant c~0:1 if the
individual was infected and zero otherwise.
The epidemic was simulated as a Poisson process, i.e. as a series
of random independent events occurring at given average rates in
continuous time. In this model the possible events were infection of
a susceptible individual and recovery of an infected individual.
The average infection rate rI within a group was estimated as the
sum of the pairwise transmission parameters bjk of the group
members and the average recovery rate rR as the sum of the
individual speeds of recovery cj.
The simulated epidemic was started by a single randomly
chosen infected individual within each group of size n in an
otherwise naı ¨ve population. The time to the next event (inter-event
times) and the corresponding event type (infection of a susceptible
individual or recovery of an infected individual) were then
estimated using Gillespie’s direct algorithm [20] which is a
commonly used algorithm in stochastic epidemiological models
[21]. Specifically, the inter-event times for each group were
sampled from an exponential distribution with parameter
r~rIzrR. In other words, the time between each event was
estimated as {ln(x1)=r where x1 , U(0,1). The specific event
type v (i.e. infection or recovery) which then occurs was obtained
by drawing a random variate from a discrete distribution with
probability p(v)~rv=r. Hence, the event was an infection if
x2vrI=r where x2 , U(0,1) and a recovery otherwise. The
individual involved in each event was then chosen randomly
weighted by the individuals’ susceptibility or recovery rate. No
transmission was assumed between groups.
Simulated Populations
In order to ensure a high power to detect genetic variation, large
populations with a relatively large family size and a family
structure following e.g. dairy cattle were simulated. In particular,
populations of size N=100,000 were created with a paternal half-
sib structure and no full sibs. All parents were assumed to be
unrelated. The half sib family size was 100 individuals. Similarly,
in order to ensure a high power to detect genetic variation, each
population was divided into 10,000 groups of size 10 chosen at
random without reference to pedigree.
Breeding values for susceptibility and infectivity were assigned
to the individuals in the parental generation using different
distributions to account for different underlying genetic architec-
tures. For the first architecture it was assumed that genetic
variation in susceptibility was controlled by a single bi-allelic locus
and genetic variation in infectivity by another bi-allelic locus. Both
loci were assumed to segregate independently. This architecture
Indirect Genetic Effects of Infectious Disease
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example, Houston et al. [22] found that a single quantitative trait
locus (QTL) explained 98% of the additive genetic variation in
susceptibility to infectious pancreatic necrosis (IPN) in Salmon. For
the second architecture it was assumed that genetic variation in
these traits is influenced by many alleles conferring a continuous
distribution of effect sizes (possibly stemming from several loci).
Parametric statistical analyses usually assume normality. How-
ever, as shown by Lloyd-Smith et al. [11], the distribution of
infectivity is often right-skewed. Moreover, skewed distributions
allow for larger variation when the distribution is confined to
positive values. Both types of genetic architectures were, therefore,
considered with either a symmetrical or a right-skewed frequency
distribution. In all four combinations (two alleles- symmetric, two
alleles- skewed, multiple alleles – symmetric, multiple alleles –
skewed) mean susceptibility and infectivity were fixed at m=0.22,
as different population means would lead to different prevalence
profiles. Fixing the means does however imply that populations
with different genetic architectures have different input variances,
and may thus not be directly comparable. However the focus of
the study is comparison of animal models vs. IGE models within a
genetic architecture.
Two alleles genetic architecture. For the bi-allelic archi-
tecture, it was assumed that the locus influencing susceptibility has
two alleles each inferring a value of G1 or G2 and the locus
influencing infectivity has two alleles each inferring a value of F1
or F2. We also assumed additivity of allelic effects without
dominance and that the population is in Hardy-Weinberg
equilibrium. In other words, the genetic values for susceptibility
(or infectivity) in the parental population were sampled from a
discrete distribution with three possible values G1+G1 (or F1+F1),
G1+G2 (or F1+F2) and G2+G2 (or F2+F2). The shape of the
distribution was defined through the minor allele frequency (MAF)
which applied to the allele with a large effect (F2, G2). The values
corresponding to each of the alleles were then chosen such that the
population mean and the allele substitution effect a were kept
constant. The same parameters were used for both infectivity and
susceptibility to facilitate comparison of estimated genetic param-
eters. Table 2 shows the parameter values for the bi-allelic genetic
architecture. The offspring’s’ breeding values were then generated
Table 1. Symbols and Notations.
gj Susceptibility of individual j
fj Infectivity of individual j
cj Speed of recovery of individual j
c Speed of recovery constant
bjk Pairwise transmission parameter from individual k to individual j
rI Average rate of infection
rR Average rate of recovery
X1,x2 Random variates
U(0,1) Uniform distribution between zero and one
N Population size
N Group size
m Fixed mean of susceptibility and infectivity
G1 Effect of allele with small effect on susceptibility, in bi-allelic architecture
G2 Effect of allele with large effect on susceptibility, in bi-allelic architecture
F1 Effect of allele with small effect on infectivity, in bi-allelic architecture
F2 Effect of allele with large effect on infectivity, in bi-allelic architecture
MAF Minor allele frequency (right-skewed distribution, applies to allele with large effect)
A Allele substitution effect
N(m,s
2) Normal distribution with mean m and variance s
2
G(a,h) Gamma distribution with shape a and scale h
s2
A Genetic variance from conventional model
s2
D Direct genetic variance from IGE model
s2
S Indirect genetic variance from IGE model
s2
e Residual variance
B1,b 2 Regression coefficients
  p p Mean number of infected groupmates
EBVA Estimated Breeding Values from the conventional model
EBVD Estimated Breeding Values for the direct effect from the IGE model
EBVS EBV for the indirect effect from the IGE model
Ix Index of Estimated Breeding Values
R0 Basic reproduction number: expected number of secondary infections caused by an individual in its lifetime.
doi:10.1371/journal.pone.0039551.t001
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allele from each parent.
Multiple alleles genetic architecture. For the multiple
alleles architecture, it was assumed that there would be sufficient
alleles contributing to the additive genetic values of susceptibility
and infectivity in the parental population to be adequately
approximated by a continuous probability density function.
For the symmetric frequency distribution, the breeding values
for the parental population were sampled from the normal
distribution N(m, s
2). The parameter values were taken as m=0.22
(i.e. the same as for the bi-allelic architecture) and s
2=0.005 to
avoid frequent negative values of susceptibility/infectivity
(Table 2). If a negative value was sampled, it was discarded and
re-sampled. Each offspring was allocated a breeding value equal to
the mean of its parents plus a Mendelian sampling term.
For the skewed frequency distribution, the breeding values of
the parental population for susceptibility and infectivity were
assumed to be distributed according to the gamma distribution
G(a,h). It is not possible to represent Mendelian inheritance by
adding a Mendelian sampling term with a gamma distribution,
however, as the offspring generation would no longer follow the
same distribution as the parental generation. It was therefore
assumed that the parental breeding values stem from ten additive
loci with a large number of alleles each, whose values follow the
gamma distribution G(a/20,h). The offspring were then randomly
assigned one allele from each parent for each locus. The breeding
values of the offspring are therefore distributed following G(a,h).
Specifically, the parameters were taken as a=1.1 and h=0.2 such
that the mean ah=m=0.22, i.e. the same as for the bi-allelic
architecture, the variance ah
2=0.044 (Table 2) and the distribu-
tion is right-skewed (skewness 2/!a=1.9).
For all populations, it was assumed that susceptibility and
infectivity are fully heritable and that the outcome, i.e. whether an
individual becomes infected or not, depends on both, the genetics
and environment. The environmental contribution to the pheno-
typic variance was represented through the stochastic events
(infection, recovery) in the epidemiological model. Thus, the
model assumes genetic predisposition whilst maintaining full
environmental stochasticity of the epidemics. Moreover, adding
additional environmental noise would not provide further useful
information to this study and would make it harder to interpret the
results. Each architecture was run with variation introduced in
susceptibility only, infectivity only, both or neither. When no
variation in susceptibility/infectivity was introduced, all individu-
als were given a fixed breeding value of m=0.22 for that
underlying trait. As each simulated population is divided into
10,000 groups, i.e. 10,000 independent epidemics, each simulation
was replicated ten times.
Estimating genetic variance. Genetic variation between
individuals was estimated from binary records which were
obtained by recording the disease state of simulated individuals.
The binary disease trait, disease presence, was one if an individual
had become infected prior to a considered time-point and zero
otherwise. The data were analysed at the same timepoint for all
groups, which was the time at which 50% of individuals would
have become infected in a homogeneous population with the same
mean values for the input parameters. All analyses were carried
out using ASRem [23].
To reflect current practise, genetic variance in disease presence
was first estimated with a mixed model including a single genetic
variance. In order to be in line with the indirect genetic effect
model, this was achieved with an animal model for disease
presence y observed in offspring j of sire i,
yjh*meanz(animal effect)jzejh: ð2Þ
The group effect is absorbed by allowing for a correlation
between the residuals of group members, this is equivalent to
fitting a random group effect [24]. The animal variance is denoted
as sA
2. Hereafter this model is referred to as the conventional
model.
To estimate the genetic variance in the indirect effect, the data
were analysed using the model developed by Muir et al. [16]. Thus
for disease presence y observed in offspring j with this individual
living in group h of size n with groupmates m,
yjh*meanz(direct effect)jz
X n{1
m~1
(associative effect)mhzejh: ð3Þ
Similarly to the conventional model, the group effect is
absorbed by allowing for a correlation between the residuals of
group members [24]. Note that this model does not take account
of the disease status of individuals j and their group members m,i n
other words, it is assumed that all individuals express the direct
effect (susceptibility) and the associative effect (infectivity) at all
times, regardless of their infection status. The variance of the
direct and indirect genetic effects are denoted sD
2 and sS
2
respectively. Hereafter this model is referred to as the Indirect
Genetic Effects (IGE) model.
Association between variation in susceptibility/
infectivity and variation in binary disease presence. In
order to assess to what extent the available genetic variation is
being captured by the different statistical models, an estimate of
expected output variance as a function of the input variance in
infectivity/susceptibility is required. Following Dempster and
Lerner [25] a linear relationship was assumed between input
and output traits to provide an approximation. In particular, it was
Table 2. Parameters for Breeding Values Generation.
M.A.F. Allele values a Population mean m Variance
Distribution F1,G1 F2,G2
Two alleles Symmetric 0.5 0.02 0.2 0.18 0.22 0.0162
Skewed 0.2 0.074 0.254 0.18 0.22 0.0104
Multiple alleles Symmetric - - - - 0.22 0.0049
Skewed - - - - 0.22 0.0440
MAF applied to the alleles with a large effect (F2, G2).
doi:10.1371/journal.pone.0039551.t002
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presence in an individual j and that individual’s susceptibility gj
and the sum of the infectivities f of the p infected groupmates of
that individual,
yjh*meanzb1gjzb2
X p
m~1
fmhzejh: ð4Þ
The regression mean and coefficients b1 and b2, were estimated
using this linear model in the statistical package R [26] with the
known input (i.e. true f and g values) and output (y) data from the
simulations. Hence the model in Equation 4 was used to estimate
the true linear effects of infectivity and susceptibility to the
observed binary disease presence.
The number of groupmates that have been infected (p) is a
variable which depends on the group h and status of individual j.
Indeed, if in a given group x individuals have been infected,
individual j will have x groupmates which have been infected if it is
susceptible and x21 if it is one of the infected individuals. The
variance of disease presence s
2 may therefore be expressed as
follows (cf. derivation in Text S2):
s2~b2
1s2
gzb2
2  p ps2
fzb2
2  f f 2s2
pzs2
e: ð5Þ
This expression can be compared with the estimated variance of
disease presence ^ s s2 that is obtained from the IGE model in
equation (3),
^ s s2~s2
Dz(n{1)s2
Szs2
e’: ð6Þ
The first term in equation (5) is a function of the input variance
in susceptibility s2
g and should be approximately comparable to s2
D
from the IGE model and to s2
A from the conventional model. The
second term in equation (5) is a function of the input variance in
infectivity s2
f and mean number of infected groupmates   p p over all
groups, and should be approximately comparable to (n{1)s2
S, i.e.
the second term in equation (6). The third term is a function of the
squared input mean infectivity   f f 2 and the variance in number of
infected groupmates s2
p It is not directly comparable with any
ASReml output as this term includes both between group
variation and interaction between infectivity and susceptibility.
Note that the expression of infectivity depends on the individual
being infected, which in turn depends on the individuals’ own
susceptibility, and s2
p can be said to be the variation in numbers of
individuals expressing infectivity. The interdependence in this
model between infectivity and susceptibility is likely to be partly
captured through a non-zero covariance estimate between direct
and indirect genetic effects in ASReml [23].
Estimated response to selection
In order to estimate response to selection based on Estimated
Breeding Values (EBVs) derived from the conventional and IGE
models, the impact of selection on true mean susceptibility/
infectivity was examined. Here the population mean susceptibil-
ity/infectivity was compared to the mean susceptibility/infectivity
after selection of 10% of the individuals with the lowest EBVs
obtained from each model. For the conventional model, selection
used the only available EBV (EBVA). For the IGE model, selection
was based on the EBVs for direct (EBVD) and indirect (EBVS)
genetic effect separately as well as for the index Ix = EBVD +
(n21)   p p EBVS. The weight of the index was selected to take the
mean level of exposure i.e. (n21)   p p into account.
To quantify response to selection in terms of risk and severity of
the epidemic, the basic reproduction number R0 was estimated for
the whole population and for each selected subpopulation using
the true values of susceptibility and infectivity. R0 is the mean
number of secondary infections an infected individual will cause in
its lifetime and is commonly used as a measure of disease risk and
severity in epidemiology [27]. By definition, an epidemic will die
out if R0,1. Following a SIR model for a closed population,
R0~bS0=c, with S0=(n21) being the initial number of suscep-
tible individuals in a group [19]. Incorporating equation (1) and
taking a Taylor series expansion we obtain,
R0~{ ln(1{  g g  f f)S0
  
=c: ð7Þ
The symmetry of susceptibility and infectivity in equation (7)
implies that a decrease in mean susceptibility or infectivity will
decrease mean R0 equally (cf. Figure S1, Text S3).
Results
Estimated genetic variance in disease presence using a
conventional model
The estimated variances in disease presence obtained for each
population using a conventional model, along with the mean
presence over all groups in all replicates, are displayed in Table 3.
Overall the variance estimates depend on input variance and on
mean presence at time of evaluation. As input parameters were the
same for susceptibility and infectivity, variance estimates along the
rows of Table 3, where mean presence is the same, are directly
comparable. Note that values in rows are not directly comparable,
on the other hand, across columns with different mean presence.
The results indicate that, if there is variation in infectivity only,
the conventional model fails to pick up the heritable variation in
binary disease presence present in the data. Only in the
populations with a skewed multiple allele genetic architecture
(i.e. large variance in infectivity) a small amount of genetic
variation is captured when there is variation in infectivity only.
However, the resulting variance estimate was only 3.5% of that
compared to populations with the same variance introduced in
susceptibility.
Estimated genetic variances using an IGE model
Given that the prevalence profiles were similar between genetic
architectures (cf. Figures S2 & S3, Text S3) and the skewed
multiple alleles population had the largest input variance, analyses
using the IGE model were only performed on populations with
skewed distributions for susceptibility and infectivity.
The genetic parameters obtained by analysis with the IGE
model along with relevant statistics are displayed in Tables 4 & 5.
Note that following equation (6) the contribution of the indirect
genetic effect to the phenotypic variance is (n21) times greater
than the values in Tables 4 & 5. Variance in infectivity is captured
by the sS
2, in populations with both genetic architectures (cf.
Tables 4 & 5). A log-likelihood test was performed to evaluate the
statistical significance of the indirect genetic effects term. As would
be expected, the indirect genetic effects term was significant
(P,0.05) in populations with variation in infectivity (cf. Table 5).
The analysis of the skewed multiple alleles population also implies
that there is a statistically significant positive genetic covariance
Indirect Genetic Effects of Infectious Disease
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susceptibility (cf. Tables 4 & 5), despite susceptibility and infectivity
being independent in our simulation. This is probably due to the
fact that the model fitted assumes constant expression of effects by
all group members whereas an individual will only express
infectivity if infected, which will depend on the individual’s
susceptibility. Note that the values in Tables 4 & 5 were obtained
from the same data as those in Table 3, so the values in Table 3
can be compared to those in Tables 4 & 5.
Table 3. Estimated Genetic Variance in Disease Presence (Binary) Using a Conventional Animal Model.
Variation introduced in:
Distribution None Infectivity Susceptibility Both
Two alleles Symmetric Variance 0.32#60.08 0.63#60.09 25.3560.27 18.7460.45
Mean presence 0.56 0.50 0.51 0.46
Skewed Variance 0.32#60.08 0.37#60.10 8.2860.14 7.9660.13
Mean presence 0.56 0.53 0.53 0.51
Multiple alleles Symmetric Variance 0.13#60.04 0.09#60.08 0.12#60.09 0.10#60.03
Mean presence 0.51 0.48 0.49 0.50
Skewed Variance 0.24#60.08 0.7460.09 31.0260.53 18.5660.45
Mean presence 0.51 0.42 0.42 0.35
All parameters as in table 2. 10000 groups of size 10, ‘#’ means not significantly different from zero (P.0.05), values scaled by 10
3.
doi:10.1371/journal.pone.0039551.t003
Table 4. Estimated Genetic Variance in Disease Presence (Binary), in Populations with a Skewed Bi-Allelic Genetic Architecture
Underlying Susceptibility/Infectivity, Using the Indirect Genetic Effects Model.
Variation introduced in:
Estimated genetic variance/covariance in: None Infectivity Susceptibility Both
Direct effect s2
D 0.32#60.09 0.22#60.11 9.1960.30 8.6360.16
Indirect effect s2
S 0.14#60.04 0.5160.04 0.16#60.03 0.4360.05
Direct/indirect effect sDS 0.06#60.04 0.08#60.08 0.45#60.14 0.59#60.13
Log likelihood test P-value 0.4 0.3*10
22 0.5 0.04
Mean presence 0.56 0.53 0.53 0.51
Values scaled by 10
3,‘ #’ means not significantly different from zero (P.0.05). Values along the rows are directly comparable to each other where mean presence is the
same. Estimates averaged over ten iterations. Parameter values as in Table 2, 10000 groups of size 10. The log-likelihood P-value refers to the significance of the indirect
genetic effect.
doi:10.1371/journal.pone.0039551.t004
Table 5. Estimated Genetic Variance in Disease Presence (Binary), in Populations with a Skewed Multiple Alleles Genetic
Architecture Underlying Susceptibility/Infectivity, Using the Indirect Genetic Effects Model.
Variation introduced in:
Estimated genetic variance/covariance in: None Infectivity Susceptibility Both
Direct effect s2
D 0.26#60.09 0.36#60.11 28.0761.97 19.5560.47
Indirect effect s2
S 0.16#60.03 1.0060.09 0.11#60.04 0.4360.04
Direct and indirect effect sDS 0.08#60.05 0.13#60.09 1.0560.29 0.8660.09
Log likelihood test P-value 0.5 0.2*10
25 0.5 0.3*10
22
Mean presence 0.51 0.42 0.42 0.35
Values scaled by10
3,‘ #’ means not significantly different from zero (P.0.05). Values along the rows are directly comparable to each other where mean presence is the
same. Estimates averaged over ten replicates. Parameters as in Table 2, 10000 groups of size 10. The log-likelihood P-value refers to the significance of the indirect
genetic effect.
doi:10.1371/journal.pone.0039551.t005
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Input variance in susceptibility and infectivity and estimated
variances were brought to a comparable scale using equations (5)
and (6) and are displayed in Table 6. From Table 6 it is evident
that the first term in equation (5), sD
2, and sA
2 are approximately
similar. However, the second term in equation (5) appears to be
consistently larger than (n21)sS
2, suggesting that the IGE model
underestimates variation in infectivity. This could be due to the
fact that the IGE model assumes constant expression of infectivity
by all group-members, whereas in equation (5) expression of
infectivity is limited to infected individuals. In this way the indirect
effect is distributed between (n21) individuals, in the genetic
analysis with the IGE model, compared to   p p in equation (5) with
  p pƒn{1. The discrepancy in these variance estimates suggests that
there is some scope for improvement.
Impact of selection on mean susceptibility/infectivity and
future disease risk
Mean susceptibility and infectivity, of the whole population and
selected sub-populations, together with their respective average R0
values are displayed in Table 7. In line with our previous results,
selection on the breeding values derived from the conventional
model or on EBVD alone, only reduces mean susceptibility (cf.
Table 7). Less predictably, however, selection on EBVS reduced
both mean infectivity and susceptibility (cf. Table 7). This may be
due to expression of infectivity being dependent on being infected,
which in turn depends on susceptibility as mentioned above. This
suggests that, when status isn’t taken into account, selection
targeting infectivity would indirectly also select for lower
susceptibility. However, the resulting average R0 values displayed
in Table 7 suggest that an index with both direct and indirect
breeding values would create the greatest impact for the reduction
of disease in future generation.
Discussion
The hypothesis of this study was that low heritability estimates
of disease traits may not reflect the true additive genetic variation
inherent in a population, but rather a deficiency in the philosophy
underpinning the models that are currently fitted. The aim of this
study was therefore to assess whether it is possible to capture
genetic variation in infectivity, when it is inherent in the data, with
current statistical methods (animal/sire and IGE model). This was
assessed for a variety of genetic architectures underlying suscep-
tibility and infectivity. Our results show that, unlike a conventional
model, which does not capture the variation in infectivity when it
is presesnt in the data, a model which takes indirect genetic effects
(IGE) into account captures some, though not all, of the inherent
genetic variation in infectivity. This implies that, failing to include
indirect genetic effects when analysing disease data from field
studies may result in substantial genetic variation being missed.
For example had the QTL, explaining 98% of the additive genetic
variation in susceptibility to pancreatic necrosis in Salmon, found
by Houston et al. [22] affected infectivity rather than susceptibility
Table 6. A Comparison of Expected and Observed Variance Components for the Skewed ‘Multiple Alleles’ and ‘Two Alleles’
Architectures When Genetic Variance Is Introduced INTO Infectivity, or Susceptibility, or Both.
Expected: IGE: Conventional: Expected: IGE:
Variation introduced in: Susceptibility Direct Infectivity Indirect
b2
1s2
g s2
D s2
A b2
2  p ps2
f (n{1)s2
S
Multiple Alleles Infectivity 0.00 0.36
# 0.74 15.46 9.04
Susceptibility 36.46 28.07 31.02 0.00 0.99
#
Both 20.39 19.55 18.56 9.20 3.87
Two Alleles Infectivity 0.00 0.22
# 0.37
# 6.34 4.59
Susceptibility 8.86 9.19 8.60 0.00 1.44
#
Both 7.92 8.63 7.96 5.34 3.87
Observed components are taken from results of analyses of data with either a conventional model (Eqn 2) or IGE model (Eqn 3), whilst expected componentsa r e
obtained from the true simulated values and Eqn 5. ‘#’ means not significantly different from zero (P.0.05), values scaled by 10
3.
doi:10.1371/journal.pone.0039551.t006
Table 7. Mean Susceptibility and Infectivity following Selection Using the Conventional Animal Model or the Indirect Genetic
Effects Model.
Selection
Mean
susceptibility
Mean
infectivity R0
None 0.22 0.22 4.46
Conventional animal effect EBV 0.10 0.22 1.9960.04
Direct effect EBVD 0.10 0.22 1.9660.04
Indirect effect EBVs 0.15 0.17 2.3860.11
Index Ix=EBVD+  p p (n21) EBVs 0.11 0.19 1.9160.03
Population with variation in both infectivity and susceptibility following a skewed multiple allele genetic architecture. 10000 groups of size 10. Proportion selected was
0.10. Values 6 standard error when greater than 0.005.
doi:10.1371/journal.pone.0039551.t007
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genetic variance does not come at the expense of obtaining reliable
estimates for genetic variance in susceptibility.
Our results show further that the ability of IGE models to detect
genetic variance in infectivity can impact on response to
subsequent artificial selection. From the mean susceptibility/
infectivity and R0 values of the selected subsets of the population it
is evident, that even with BVs estimated with the current IGE
model based on binary data from a single time point, a greater
impact on disease risk and severity could be achieved than by
using BVs estimated with a conventional model. This is
particularly true in populations with variation in infectivity only,
as no selection would have been possible based on breeding values
derived from a conventional model. At present, it is unknown
whether infectivity harbours substantial genetic variation, or
whether populations with genetic variation in infectivity only are
common. This work, however, provides the first tools to address
these questions.
Comparison with expected genetic variance from an alternative
model using linear approximations suggests that there is still scope
for improvement in applying IGE models to disease data. The
apparent underestimation of genetic variance in infectivity may be
due to the fact that the current methodology does not allow for
status dependence. This could potentially cause an underestima-
tion of the variance in infectivity as the indirect genetic effect is
attributed to all individuals in a group when in reality it will have
been expressed by only a subset of group members. Furthermore,
our analysis revealed that the statistical model applied here is likely
to yield a positive covariance estimate despite susceptibility and
infectivity being independent. This is probably because expression
of infectivity is state dependent and thus partly depends on the
individual’s susceptibility. Allowing for status dependency should
therefore improve the accuracy of the estimated genetic param-
eters, suggesting that responses to selection may be greater than
values presented here when methods are further improved.
The data of this study were generated using a standard
epidemiological SIR model, assuming only host genetic variation
in susceptibility and infectivity and full independence and
heritability for both traits, in order to reduce unnecessary noise.
Moreover, potential host-pathogen interactions were not consid-
ered. Although these assumptions may be representative for a
variety of infectious diseases and populations, one would expect
that the different sources of variances for diseases with more
complex epidemiological patterns and in populations with more
complex variance and co-variance structure would be more
difficult to capture. This enhances the need for further investiga-
tions of IGE models with regards to requirements for data
collection and experimental design for obtaining reliable genetic
parameter estimates corresponding to host susceptibility and
infectivity.
In addition to susceptibility and infectivity investigated here,
there may be other sources of host genetic variation contributing
to genetic variance of disease data and thus amenable for selection.
For example, in addition to variation in infectivity, i.e. the
propensity of individuals to infect others upon contact, genetic
differences in transmission patterns may be caused by heritable
variation in contact rate due to behavioural traits such as
aggression or promiscuity. Previous studies have demonstrated
[24] that IGE models are able to provide reliable estimates for
these social interactions. Moreover, additional heritable variation
in disease presence may come from genetic differences in recovery
time among individuals, which affects their infective period.
Analyses accounting for genetic differences in the length of the
infective period may contribute to achieving greater response to
selection, and emphasizes the scope for additional work in this
area. We achieved a first step in understanding and extending the
range of epidemiological parameters under potential host genetic
influence that can be estimated with current quantitative genetic
models. Further work is required to increase our understanding
and improve the statistical models through the use of simulations
and the application to field data.
Bishop and Woolliams [4] have shown that accuracy of genetic
parameters for disease data obtained from field studies depends
largely on exposure, and thus on time of measurement. Disease
records obtained at a time corresponding to high disease
prevalence are expected to give higher heritability estimates than
disease records obtained at times when prevalence was low. It is
expected that similar relationships also apply for the estimation of
genetic parameters associated with indirect genetic effects.
Further, Bijma [28] has shown that substantial improvement in
accuracy of indirect genetic variance components can be achieved
by optimising group size and composition. Since group size has a
strong effect on disease progression between individuals and thus
on prevalence patterns (cf. Text S3, Figures S2 & S3), it is
expected that much improvement in the estimation of indirect
genetic effects could be obtained by choosing the correct
combination of group size and time at which records are collected.
This could be combined with groups composed of members of two
families, which yields much better accuracy of estimated genetic
parameters than groups composed at random, particularly when
groups are large [28]. Moreover, different weightings for the direct
and indirect effects EBVs in the index might offer further
improvements depending on the context.
One of the remaining challenges of analysing binary disease
data with an IGE model is to establish the relationship between
underlying susceptibility/infectivity and direct/indirect genetic
effects. There are two standard ways of estimating genetic
parameters from a binary trait, either using a linear mixed model,
which treats the data as continuous and includes random factors,
or a generalised linear model (GLM). The use of a GLM in
combination with random factors (GLMM) is an area that is open
to question. In fact, ASReml [23], the software used to fit the
models in this paper, provides a warning not to use a GLM in
combination with random factors. The relationship between the
underlying traits, susceptibility and infectivity, and the observed
trait disease presence is complex and stochastic. It is therefore
questionable whether canonical link functions relating underlying
parameters (e.g. susceptibility, infectivity) with the probability of
observing an event (e.g. becoming infected), such as probit or
logistic functions, would be appropriate in our case. In fact
variance estimates obtained using a logistic model are not on the
same scale as susceptibility and infectivity (cf. Text S4, Table S2).
Moreover, should we use non-standard distributions and link
functions, further statistical issues would arise, e.g. decomposing
the phenotypic variance into genetic and environmental compo-
nents may no longer be valid. Hence there is no theoretical
apparent benefit in applying specific link functions with a GLM.
Moreover, variance estimates obtained with a logistic model are
qualitatively the same as those obtained with the linear models (cf.
Text S4, Table S2). Besides, selection on the EBVs obtained with
a logistic model provided no better results with regards to R0 (cf.
Text S4, Table S3). We therefore decided to use a linear mixed
model, which have been shown to provide estimates of genetic
parameters of sufficient accuracy to generate selection response
(e.g. [29,30]).
Better understanding of the factors involved in indirect genetic
effects to disease presence could open up further potential for
disease control through selection. For example, it has been shown
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depends on the covariance between the direct and indirect genetic
effects [14], which correspond to susceptibility and infectivity in
our study. In this study we assumed that infectivity and
susceptibility are independent. However, should they be positively
correlated, the expected response to selection would be greater
than indicated here. Doeschl-Wilson et al. [31] demonstrate for
gastro-intestinal parasitism in sheep that correlation between
underlying disease traits can have profound impact on heritabil-
ities of observable disease traits and thus on response to selection.
Moreover, a recent study showed molecular evidence for a positive
correlation between susceptibility and infectivity as the known
immunosuppressant stress hormone norepinephrine was shown to
cause increase shedding of Salmonella [32]. It is therefore
reasonable to believe that being able to estimate variance in
indirect genetic effects for disease may open up new avenues for
the control of infectious diseases through selection. In conclusion,
this is the first work on the relevance of indirect genetic effects for
the spread of infectious disease and it indicates that their relevance
extends beyond behavioural interactions among individuals, which
is the current focus of such research (e.g. [33]).
Supporting Information
Figure S1 Predicted disease prevalence over time.
Homogeneous population for suceptibility (high g =0.4, low g
=0.04) and infectivity (high f =0.4, low f =0.04). Population
consists of 500 groups of size 40 as in Table S1. Prevalence was
averaged over all groups over three iterations. Probability of
disease emerging in a group was 0.38 in the population with low
susceptibility and infectivity and 1 for the other populations. The
expected course of the epidemic is identical for high infectivity/
low susceptibility and low infectivity/high susceptibility.
(TIF)
Figure S2 Disease prevalence over time assuming many
underlying alleles of varying effect coding for suscepti-
bility or infectivity and a skewed distribution. Parameters
as in Table 2. Population structure parameters as in Table S1. A)
groupsize of 10 B) groupsize of 40 C) groupsize of 400.
(TIF)
Figure S3 Disease prevalence over time assuming two
alleles code for susceptibility or infectivity and a
symmetrical distribution. Parameters as in Table 2. Popu-
lation structure parameters as in Table S1. A) groupsize of 10 B)
groupsize of 40 C) groupsize of 400.
(TIF)
Table S1 Population structure parameters.
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Table S2 Variance estimates using a logistic link
function.
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Table S3 Mean susceptibility and infectivity following
selection using the conventional animal model or the
Indirect Genetic Effects model with a logistic link
function.
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Text S1 Derivation of transmission parameter from
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profiles.
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estimates and selection response.
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